BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24864059)

  • 1. Prevalence of actinic keratosis among dermatology outpatients in Austria.
    Eder J; Prillinger K; Korn A; Geroldinger A; Trautinger F
    Br J Dermatol; 2014 Dec; 171(6):1415-21. PubMed ID: 24864059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of actinic keratosis among dermatology outpatients in Spain.
    Ferrándiz C; Plazas MJ; Sabaté M; Palomino R;
    Actas Dermosifiliogr; 2016 Oct; 107(8):674-80. PubMed ID: 27445129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Actinic Keratosis in Patients Attending General Practitioners in Switzerland.
    Dziunycz PJ; Schuller E; Hofbauer GFL
    Dermatology; 2018; 234(5-6):214-219. PubMed ID: 30125890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China.
    Zhao Y; Li CY; Wen CM; Wei YB; Li RY; Wang G; Tu P
    Br J Dermatol; 2016 May; 174(5):1005-10. PubMed ID: 26650251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study.
    Flohil SC; van der Leest RJ; Dowlatshahi EA; Hofman A; de Vries E; Nijsten T
    J Invest Dermatol; 2013 Aug; 133(8):1971-8. PubMed ID: 23510990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and awareness of actinic keratosis: barriers and opportunities.
    Rosen T; Lebwohl MG
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S2-9. PubMed ID: 23228302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic.
    Yaldiz M
    Medicine (Baltimore); 2019 Jul; 98(28):e16465. PubMed ID: 31305480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma.
    Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics.
    Fargnoli MC; Altomare G; Benati E; Borgia F; Broganelli P; Carbone A; Chimenti S; Donato S; Girolomoni G; Micali G; Moggio E; Parodi A; Piaserico S; Pistone G; Potenza C; Puviani M; Raucci M; Vaccari S; Veglio S; Zanca A; Peris K
    Eur J Dermatol; 2017 Dec; 27(6):599-608. PubMed ID: 29311040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of actinic keratoses.
    Green AC
    Curr Probl Dermatol; 2015; 46():1-7. PubMed ID: 25561199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of actinic keratoses in Germany--analysis of multisource data.
    Schaefer I; Augustin M; Spehr C; Reusch M; Kornek T
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):309-13. PubMed ID: 23347271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists.
    Strohal R; Kerl H; Schuster L
    J Drugs Dermatol; 2012 May; 11(5):574-8. PubMed ID: 22527424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actinic keratoses in subjects from la Mitad del Mundo, Ecuador.
    Fors M; González P; Viada C; Falcón K; Palacios S
    BMC Dermatol; 2020 Oct; 20(1):11. PubMed ID: 33109125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
    Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
    Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
    Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
    Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications.
    Feldman SR; Fleischer AB
    Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses.
    Rishpon A; Kim N; Scope A; Porges L; Oliviero MC; Braun RP; Marghoob AA; Fox CA; Rabinovitz HS
    Arch Dermatol; 2009 Jul; 145(7):766-72. PubMed ID: 19620557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.